Overview

Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms

Status:
Completed
Trial end date:
2008-06-01
Target enrollment:
Participant gender:
Summary
This study evaluates the performance and acceptance of Optive versus Hylocomod eyedrops, when administered for one month to patients with mild to moderate dry eye symptoms, with and without contact lenses.
Phase:
Phase 4
Details
Lead Sponsor:
Allergan
Treatments:
Carboxymethylcellulose Sodium
Glycerol
Hyaluronic Acid
Ophthalmic Solutions
Tetrahydrozoline